Great Point Partners LLC Vericel Corp Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$30.93 - $59.48 $27.8 Million - $53.5 Million
-900,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$18.53 - $31.5 $10.8 Million - $18.3 Million
-580,787 Reduced 39.22%
900,000 $27.8 Million
Q3 2020

Nov 16, 2020
SELL
$14.68 - $19.12 $1.9 Million - $2.47 Million
-129,367 Reduced 8.03%
1,480,787 $27.4 Million
Q2 2020

Aug 14, 2020
BUY
$8.5 - $15.82 $13.7 Million - $25.5 Million
1,610,154 New
1,610,154 $22.3 Million

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.8M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.79B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email